Search Results - "Cywin, Charles L"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket by Tong, Liang, Pav, Susan, White, Della M, Rogers, Sheri, Crane, Kathy M, Cywin, Charles L, Brown, Maryanne L, Pargellis, Christopher A

    Published in Nature structural biology (01-04-1997)
    “…The crystal structure of human p38 mitogen-activated protein (MAP) kinase in complex with a potent and highly specific pyridinyl-imidazole inhibitor has been…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Rapid synthesis of an array of trisubstituted urea-based soluble epoxide hydrolase inhibitors facilitated by a novel solid-phase method by Kowalski, Jennifer A., Swinamer, Alan D., Muegge, Ingo, Eldrup, Anne B., Kukulka, Alison, Cywin, Charles L., De Lombaert, Stéphane

    Published in Bioorganic & medicinal chemistry letters (15-06-2010)
    “…Rapid exploration of multi-dimensional SAR around a series of trisubstituted urea inhibitors of sEH was accomplished using a focused library approach. A…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Substituted 2H-isoquinolin-1-one as potent Rho-Kinase inhibitors. Part 1: Hit-to-lead account by Wu, Frank, Büttner, Frank H., Chen, Rhonda, Hickey, Eugene, Jakes, Scott, Kaplita, Paul, Kashem, Mohammed A., Kerr, Steven, Kugler, Stanley, Paw, Zofia, Prokopowicz, Anthony, Shih, Cheng-Kon, Snow, Roger, Young, Erick, Cywin, Charles L.

    Published in Bioorganic & medicinal chemistry letters (01-06-2010)
    “…Two closely related scaffolds were identified through an uHTS campaign as desirable starting points for the development of Rho-Kinase (ROCK) inhibitors. Here,…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    An orally active reversible inhibitor of cathepsin S inhibits human trans vivo delayed-type hypersensitivity by Desai, Sudha N., White, Della M., O'Shea, Kathryn M., Brown, Maryanne L., Cywin, Charles L., Spero, Denice M., Panzenbeck, Maret J.

    Published in European journal of pharmacology (24-05-2006)
    “…Cathepsin S is a major histocompatibility complex (MHC) class II associated invariant chain (Ii) degrading enzyme expressed in antigen presenting cells such as…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20